Relationship between Th17 cells and allograft
rejection
Relationship between Th17 cells and allograft
rejection
Zhikun ZHENG MM,Jinsong LI MD,Ke JIANG MD,
Department of Thoracic
Surgery, Union Hospital, Tongji Medical College, Huazhong University
of Science and Technology, Wuhan 430022, Hubei Province, China;
Abstract：Thl7 cells, a special kind of auxiliary type T cells, can secrete IL-17A, IL-17F, IL-21, IL-22, etc., as a newly discovered T-cell subset in recent years. As a different subset from the Thl and Th2 cells, Th17 cells play an important role in the development of a variety of autoimmune diseases. A current study shows that the IL-6 inflammatory response of the organization in combination with the occurrence of TGF-β can induce the differentiation of Thl7 cells. IL-23 can promote the production of IL17, as well as participate in amplification and maintenance of the survival of IL-l7 generating cells. In this process, STAT3 and ROR-γt are key transcription factors for the growing of Thl7 cells. As our knowledge on Th17 family members is rapidly growing and changing, it will be important to specify their involvement in the induction and regulation of allograft rejection in animal models as well as in clinical settings. Herein, we review the key features of Th17 cells and discuss their potential relevance to transplantation immunity.
. Relationship between Th17 cells and allograft
rejection[J]. Front. Med., 2009, 3(4): 491-494.
Zhikun ZHENG MM, Jinsong LI MD, Ke JIANG MD, . Relationship between Th17 cells and allograft
rejection. Front. Med., 2009, 3(4): 491-494.
Park H, Li Z, Yang X O, Chang S H, Nurieva R, Wang Y, Hood L, Zhu Z, Tian Q, Dong C. A distinct lineage of CD4+ T cells regulates tissue inflammation by producinginterleukin 17. Nat Immunol, 2005, 6(11): 1133–1141 doi: 10.1038/ni1261
Harrington L E, Hatton R D, Mangham P R, Weaver C T. Interleukin 17 producing CD4+ effecterT cells develop via a lineage distinct from the T helper type 1 and2 lineages. Nat Immunol, 2005, 6(11): 1123–1132 doi: 10.1038/ni1254
Aggarwal S, Ghilardi N, Xie M H, de Sauvagge F J, Gurney A L. Interleukin-23 promotes adistinct CD4+ T cells activation statecharacterized by the production of Interleukin-17. Biol Chem, 2003, 278(3): 1910–1914 doi: 10.1074/jbc.M207577200
Tato C M, O’Shea J J. What does it mean to be just17? Nature, 2006, 441(11): l66–l68
Veldhoen M, Hocking R J, Atkins C J, Locksley R M, Stockinger B. TGFbeta in the context ofan inflammatory cytokine milieu supports de novo differentiation ofIL-17-producing T cells. Immunity, 2006, 24(2): l79–189 doi: 10.1016/j.immuni.2006.01.001
Mangan P R, Harringlon L E, O’Quinn D B. Transforming growth factor-β inducesdevelopment of the TH17 lineage. Nature, 2006, 441: 231–234 doi: 10.1038/nature04754
Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu B M, Tato C, Yoshimura A, Hennighausen L, O’Shea J J. Selective regulatory function of Socs3in the formation of IL-17-secreting T cells. PNAS USA, 2006, 103(21): 8137–1842 doi: 10.1073/pnas.0600666103
Bettelli E, Carrier Y, Gao W, Korn T, Strom T B, Oukka M, Weiner H L, Kuchroo V K. Reciprocal developmental pathways for the generationof pathogenic effector ThI7 and regulatory T cells. Nature, 2006, 441(7090): 235–238 doi: 10.1038/nature04753
Langrish C L, Chen Y, Blumenschein W M, Mattson J, Basham B, Sedgwick J D, McClanahan T, Kastelein R A, Cua D J. IL-23 drives a pathogenic T cell population that inducesautoimmune inflammation. J Exp Med, 2005, 201(2): 233–240 doi: 10.1084/jem.20041257
Yang J, Jia L, Li L, Wu C Y. The differentiationand regulation of Th17 cell. Xibao Yu FenziMianyixue Zazhi, 2008, 24(3): 213–216 (in Chinese)
Ivanov I I, McKenzie B S, Zhou L, Tadokoro C E, Lepelley A, Lafaille J J, Cua D J, Littman D R. The orphan nuclear receptorRORgammat directs the differentiation program of proinflammatory IL-17+T helper cells. Cell, 2006, 126(6): 1121–1133 doi: 10.1016/j.cell.2006.07.035
Wahl S M, Wen J, Moutsopoulos N. TGF-beta: a mobile purveyor of immune privilege. Immunol Rev, 2006, 213: 213–217 doi: 10.1111/j.1600-065X.2006.00437.x
Brender C, Nielsen M, Kaltoft K, Mikkelsen G, Zhang Q, Wasik M, Billestrup N, Odum N. STAT3-mediated constitutiveexpression of SOCS-3 in cutaneous T cell lymphoma. Blood, 2001, 97(4): 1056–1062 doi: 10.1182/blood.V97.4.1056
Wormald S, Hilton D J. Inhibitors of cytokine signaltransduction. J Biol Chem, 2004, 279(2): 821–824 doi: 10.1074/jbc.R300030200
Batten M, Li J, Yi S, Kljavin N M, Danilenko D M, Lucas S, Lee J, de Sauvage F J, Ghilardi N. 1nterleukin-27 limits autoimmune encephalomyelitis bysuppressing the development of interleukin-17 producing T cells. Nat lmmunol, 2006, 7(9): 929–936
Stumhofer J S, Laurence A, Wilson E H, Huang E, Tato C M, Johnson L M, Villarino A V, Huang Q, Yoshimura A, Sehy D, Saris C J, O’Shea J J, Hennighausen L, Ernst M, Hunter C A. Interleukin-27 negatively regulates the development of interleukin-17-producingT helper cells during chronic inflammation of the central nervoussystem. Nat lmmuno1, 2006, 7(9): 937–945
Niederkorn J Y. Immunology and immunomodulation of corneal transplantation. Int Rev lmmunol, 2002, 21(2,3): 173–196
Dallman M J. Cytokines and transplantation: Thl/Th2 regulation of the immune responseto solid organ transplants in the adult. Curt Opin Immunol, 1995, 7(5): 632–638 doi: 10.1016/0952-7915(95)80069-7
Nakae S, Nambu A, Sudo K, Iwakura Y. Suppressionof immune induction of collagen-induced arthritis in IL-17-deficientmice. Immunol, 2003, 171(11): 6173–6177
Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, Sekikawa K, Asano M, Iwakura Y. Antigen-specificT cell sensitization is impaired in IL-17-deficient mice, causingsuppression of allergic cellular and humoral responses. Immunity, 2002, 17(3): 375–387 doi: 10.1016/S1074-7613(02)00391-6
Wu C Y. Th17 cell: A new subset of CD4+ T cell. Xibao YuFenziMianyixue Zazhi, 2006, 22(6): 695–697 (in Chinese)
Loong C C, Hsieh H G, Lui W Y, Chen A, Lin C Y. Evidence for the early involvement ofinterleukin-17 in human and experimental renal allograft rejection. J Pathol, 2002, 197(3): 322–332 doi: 10.1002/path.1117
Vanaudenaerde B M, Dupont L J, Wuyts W A, Verbeken E K, Meyts I, Bullens D M, Dilissen E, Luyts L, Van Raemdonck D E, Verleden G M. The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J, 2006, 27(4): 779–787 doi: 10.1183/09031936.06.00019405
Yoshida S, Haque A, Mizobuchi T, Iwata T, Chiyo M, Webb T J, Baldrige L A, Heidler K M, Cummings O W, Fujisawa T, Blum J S, Brand D D, Wilkers D S. Anti-type V collagen lymphocytesthat express IL-17 and IL-23 induce rejection pathology in fresh andwell-healed lung transplants. Am J Transplant, 2006, 6(4): 724–735 doi: 10.1111/j.1600-6143.2006.01236.x
Burlingham W J, Love R B, Jankowska-Gan E, Haynes L D, Xu Q, Bobadilla J L, Meyer K C, Hayney M S, Braun R K, Greenspan D S, Gopalakrishnan B, Cai J, Brand D D, Yoshida S, Cummings O W, Wilkes D S. IL-17―dependent cellularimmunity to collagen type V predisposes to obliterative bronchiolitisin human lung transplants. J Clin Invest, 2007, 117(11): 3498–3506 doi: 10.1172/JCI28031
Hashimoto T, Akiyama K, Kobayashi N, Mori A. Comparisonof IL-17 production by helper T cells among atopic and nonatopic asthmaticsand control subjects. Hat Arch AllergyImmunol, 2005, 137 Suppl 1: 51–54 doi: 10.1159/000085432
Li J, Simeoni E, Fleury S, Dudler J, Fiorini E, Kappenberger L, Von Segesser L K, Vassalli G. Gene transfer of solubleinterleukin-17 receptor prolongs cardiac allograft survival in a ratmodel. Eur J Cardiothorac Surg, 2006, 29(5): 779–783 doi: 10.1016/j.ejcts.2006.01.052
Tang J L, Subbotin V M, Antonysamy M A, Troutt A B, Rao A S, Thomson A W. Interleukin-17 antagonism inhibits acute but not chronicvascular rejection. Transplantation, 2001, 72(2): 348–350 doi: 10.1097/00007890-200107270-00035
Antonysamy M A, Fanslow W C, Fu F, Li W, Qian S, Troutt A B, Thomson A W. Evidence for a role of IL-17in organ allograft rejection: IL-17 promotes the functional differentiationof dendritic cell progenitors. J Immunol, 1999, 162(1): 577–584
Yuan X, Paez-Cortez J, Schmitt-Knosalla I, D’Addio F, Mfarrej B, Donnarumma M, Habicht A, Clarkson M R, Iacomini J, Glimcher L H, Sayegh M H, Ansari M J. A novel role of CD4+ Th17cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med, 2008, 205(13): 3133–3144 doi: 10.1084/jem.20081937
Kapessidon P, Poulin L, Dumoutier L, Goldman M, Renauld J C, Braun M Y. Interleukin-22 deficiency accelerates the rejection offull major histocompatibility complex-disparate heart allografts. Transplant Proc, 2008, 40(5): 1593–1597 doi: 10.1016/j.transproceed.2008.03.151
